Antiplatelet treatment with cilostazol after stent implantation

Heart

Volumn 80, Issue 4, 1998, Pages 393-396

  Yoshitomi, Y ^a   Kojima, S ^a   Sugi, T ^a   Yano, M ^a   Matsumoto, Y ^a   Kuramochi, M ^a  

^a SHIZUOKA MEDICAL CENTER   (Japan)

Author keywords

Antiplatelet treatment; Cilostazol; Stent thrombosis; Stents

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; HEPARIN; PHOSPHODIESTERASE INHIBITOR;

ANGIOGRAPHY; ARTICLE; CORONARY CARE UNIT; DEMOGRAPHY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG SCREENING; FEMALE; HEART INFARCTION; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RASH; STENT; THROMBOSIS;

EID: 0031710976     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.80.4.393     Document Type: Article

References (24)

1. George BS, Voorhees WD, Roubin GS, et al. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. J Am Coll Cardiol 1993;22:135-43.
2. Roubin GS, Cannon AD, Agrawal SK, et al. Intracoronary stenting for acute or threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992;85:916-27
3. Nath FC, Muller DWM, Ellis SG, et al. Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome. J Am Coll Cardiol 1993;21:622-7.
4. Schatz RA, Baim DS, Leon M, et al. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation 1991;83:148-61.
5. Nakamura S, Hall P, Gaglione A, et al. High pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulation. J Am Coll Cardiol 1997;29:21-7.
6. Schömig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-9.
7. Gent M, Blakely J, Easton JD, et al. The Canadian American ticlopidine study (CATS) in thromboembolic stroke. Lancet 1989;i:1215-20.
8. Hass WK, Eaton JD, Adams HP Jr, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989;321:501-7.
9. Defreyn G, Bernat A, Delebassee D, et al. Pharmacology of ticlopidine: a review. Semin Thromb Hemost 1989;15:159-66.
10. Okuda Y, Kimura Y, Yamashita K. Cilostazol. Cardiovasc Drug Rev 1993;11:451-65.
11. Ikeda Y, Kikuchi M, Murakami H. Comparison of the inhibitory effects of cilostazol, acetylsalicylic acid and ticlopidine on platelet functions ex vivo: randomized, double-blind cross-over study. Drug Research 1987;37:563-6.
12. The TIMI Study Group. The thrombolysis in acute myocardial infarction trial. N Engl J Med 1985;312:932-6.
13. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-95.
14. Haude M, Erbel R, Issa H, et al. Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents. Am Heart J 1993;126:15-22.
15. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-88.
16. Mishima Y, Tanabe T, Sakaguchi S, et al. Clinical evaluation of OPC-13013 on chronic arterial occlusive disease - a double-blind study with ticlopidine [In Japanese]. Igaku no ayumi 1986;139:133-57.
17. Okuda Y, Mizutani M, Isaka M, et al. Hemodynamic effects of cilostazol on the dorsalis pedis artery in patients with diabetic neuropathy [In Japanese]. Jpn Pharmacol Ther 1991;19:383-90.
18. Yasuda K, Tanabe T, Hashimoto M, et al. Effect of cilostazol a new antithrombotic drug, on small arterial replacement. Thromb Haemost 1985;35:1189-92.
19. Kubota Y, Kichikawa K, Uchida H, et al. Pharmacologic treatment of intimal hyperplasia after metallic stent placement in the peripheral arteries. An experimental study. Invest Radiol 1995;30:532-7.
20. Ochiai M, Isshiki T, Takeshita S, et al. Use of cilostazol, a novel antiplatelet agent, in a post-Palmaz-Schatz stenting regimen. Am J Cardiol 1997;79:1471-4.
21. Gregorini L, Marco J, Fajadet J, et al. Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilation procedures. J Am Coll Cardiol 1997;29:13-20.
22. Albiero R, Hall P, Blengino S, et al. Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation: comparison of aspirin alone versus combined ticlopidine and aspirin therapy. Circulation 1997;95:1145-56.
23. Goods C, Al-Shaibi KF, Liu MW, et al. Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting. Am J Cardiol 1996;78:1042-4.
24. Hall P, Nakamura S, Maiello L, et al. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 1996;93: 215-22.